Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Transition Therapeutics Inc    TTH   CA8937162094

 SummaryChartsNewsCompany 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
08/22/2016 08/23/2016 08/25/2016 08/26/2016 08/29/2016 Date
2.06 2.02 2.02 1.92 1.93 Last
400 700 500 180 7200 Volume
+0.98% -1.94% 0.00% -4.95% +0.52% Change
Company
Transition Therapeutics, Inc. develops novel therapeutics for disease indications.It operates through research and development of therapeutic agents segment.The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome.Its metabolic drug candidate... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on TRANSITION THERAPEUTICS IN
08/26 TRANSITION THERAPEUTICS : Announces Special Shareholder Meeting Voting Results I..
06/03 TRANSITION THERAPEUTICS : Receives Notification From NASDAQ
05/11 TRANSITION THERAPEUTICS : Announces Third Quarter Fiscal 2016 Financial Results
05/09 TRANSITION THERAPEUTICS TO HOLD CONF : 30 p.m. est
04/18 TRANSITION THERAPEUTICS : Provides Update on Type 2 Diabetes Drug Candidate TT40..
03/17 TRANSITION THERAPEUTICS : Receives Notification From NASDAQ
03/01 TRANSITION THERAPEUTICS : to Present at the 36th Annual Cowen Healthcare Confere..
02/09 TRANSITION THERAPEUTICS : Announces Second Quarter Fiscal 2016 Financial Results
02/05 TRANSITION THERAPEUTICS : to Hold Conference Call on Second Quarter Fiscal 2016 ..
02/01 TRANSITION THERAPEUTICS : Announces Top Line Phase 2 Clinical Study Results of D..
More news
Sector news : Biopharmaceuticals
04:31pDJASTRAZENECA : FDA Accepts License Application for Durvalumab
02:05pDJBayer Teams Up With Versant to Develop Stem-Cell Therapies--Update
12/08 BRISTOL MYERS SQUIBB : Meyers Squibb to pay $19.5 million to settle off-label pr..
12/07 MYLAN : EpiPen maker Mylan to restructure, cut workforce
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal -- Update
More sector news : Biopharmaceuticals
News from SeekingAlpha
08/26 Transition Therapeutics shareholders back OPKO merger
06/30 OPKO buys Transition Therapeutics in all-stock deal
06/03 Bayer expands development program for prostate cancer candidate BAY-1841788 w..
05/11 Transition Therapeutics' (TTHI) CEO Chip Brewer on Q3 2016 Results - Earnings..
05/11 Transition Therapeutics reports FQ3 results
Advertisement
Chart TRANSITION THERAPEUTICS IN
Duration : Period :
Transition Therapeutics In Technical Analysis Chart | TTH | CA8937162094 | 4-Traders
Full-screen chart
Managers
NameTitle
Tony F. Cruz Chairman & Chief Executive Officer
Carl Damiani President & Chief Operating Officer
Nicole Rusaw-George Chief Financial Officer
Aleksandra Pastrak VP-Clinical Development & Medical Officer
Michael Richard Dwyer Ashton Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
TRANSITION THERAPEUTIC..-24.90%0
BIOGEN INC-6.87%62 997
CSL LIMITED-8.47%32 515
ALEXION PHARMACEUTICAL..-33.95%28 255
BIOMARIN PHARMACEUTICA..-20.28%14 363
GRIFOLS SA-21.37%11 420
More Results